1. Home
  2. KYMR vs HNI Comparison

KYMR vs HNI Comparison

Compare KYMR & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • HNI
  • Stock Information
  • Founded
  • KYMR 2015
  • HNI 1944
  • Country
  • KYMR United States
  • HNI United States
  • Employees
  • KYMR N/A
  • HNI N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • HNI Office Equipment/Supplies/Services
  • Sector
  • KYMR Health Care
  • HNI Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • HNI Nasdaq
  • Market Cap
  • KYMR 2.7B
  • HNI 2.3B
  • IPO Year
  • KYMR 2020
  • HNI N/A
  • Fundamental
  • Price
  • KYMR $36.81
  • HNI $46.61
  • Analyst Decision
  • KYMR Buy
  • HNI Strong Buy
  • Analyst Count
  • KYMR 15
  • HNI 1
  • Target Price
  • KYMR $55.27
  • HNI $63.00
  • AVG Volume (30 Days)
  • KYMR 456.1K
  • HNI 267.3K
  • Earning Date
  • KYMR 02-27-2025
  • HNI 02-20-2025
  • Dividend Yield
  • KYMR N/A
  • HNI 2.83%
  • EPS Growth
  • KYMR N/A
  • HNI 164.22
  • EPS
  • KYMR N/A
  • HNI 2.88
  • Revenue
  • KYMR $87,563,000.00
  • HNI $2,526,400,000.00
  • Revenue This Year
  • KYMR N/A
  • HNI $5.42
  • Revenue Next Year
  • KYMR $32.89
  • HNI $2.73
  • P/E Ratio
  • KYMR N/A
  • HNI $16.18
  • Revenue Growth
  • KYMR 86.92
  • HNI 3.80
  • 52 Week Low
  • KYMR $29.24
  • HNI $40.94
  • 52 Week High
  • KYMR $53.27
  • HNI $58.42
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 42.51
  • HNI 36.37
  • Support Level
  • KYMR $36.67
  • HNI $48.18
  • Resistance Level
  • KYMR $38.24
  • HNI $50.15
  • Average True Range (ATR)
  • KYMR 1.78
  • HNI 1.46
  • MACD
  • KYMR 0.06
  • HNI -0.05
  • Stochastic Oscillator
  • KYMR 51.81
  • HNI 18.21

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

Share on Social Networks: